Connect with us


Pfizer CEO Bails On EU Testimony After Report Highlights ‘Secretive’ Vaccine Deal




Pfizer CEO Albert Bourla has bailed on an appointment to testify before the European Parliament’s special committee, where he was expected to face tough questions over secretive vaccine deals, Politico reports.

Bourla was scheduled to appear before the panel on Oct. 10, alongside key officials involved in the EUs vaccine procurement process, in order to discuss how to respond to future pandemics. According to the report, “Other pharmaceutical executives have addressed the committee, including the CEO of Moderna and senior officials from AstraZeneca and Sanofi.”

Bourla? Not so much.

The committee’s chair, Belgian MEP Kathleen Van Brempt, told POLITICO she “deeply regrets” the decision taken by Pfizer.

After a visit to BioNTech’s headquarters last week, Van Brempt had said in a written statement that she looked forward to discussions “with other CEOs” including “Mr. Albert Bourla, the CEO of Pfizer” on October 10. -Politico

In early September, an audit repirt into the EU’s vaccine procurement strategy raised questions over Bourla’s relationship with European Commission President Ursula von der Leyen before they struck a multibillion-euro vaccine deal.

The report, by the European Court of Auditors, found that von der Leyen had been directly involved in preliminary negotiations for the EU’s biggest vaccine contract, for up to 1.8 billion doses of the BioNTech/Pfizer vaccine, which was concluded in May 2021. This was a departure from the negotiating procedure followed with other contracts, where a joint negotiating team made up of officials from the Commission and member countries conducted exploratory talks. -Politico

In April, von der Leyen admitted that she had been texting with Bourla for a month straight while they were negotiating the massive contract. Two months later, the texts disappeared, triggering accusations of maladministration by the EU’s ombudsman, Emily O’Reilly,” Reuters reported at the time.

Bourla and von der Leyen’s cozy relationship was noted last year by the NYT, which Bourla told they had “developed a deep trust, because we got into deep discussions.”

“She knew details about the variants, she knew details about everything. So that made the discussion, way more engaged.”

And now Bourla won’t have to answer questions about it.

This post was originally published at Zero Hedge

Continue Reading


Anger As Djokovic Withdraws From US Open; STILL BANNED From Entering U.S. Due To Vaccination Status

“Literally the healthiest male on the planet is denied entry”



Steve Watson

Waleed Zein/Anadolu Agency via Getty Images

The world’s number one tennis player Novak Djokovic has withdrawn from the Miami Open and the U.S. Open because he is still banned from entering the country owing to his vaccination status.

While the news is being reported as a “visa dispute,” the reason Djokovic cannot complete is because he refuses to take the COVID vaccine.

Djokovic has appealed for a special dispensation to play in the tournaments, given that the restrictions are slated to end in April anyway.

Djokovic requested a vaccine waiver, however it was rejected by the Homeland Security Department in a blatant move to once make an example out of the premier athlete.

Senators Rick Scott and Marco Rubio of Florida expressed support for the 22 time grand slam victor, and called on Congress to throw out Joe Biden’s “bogus vaccine mandate.”

“It has come to our attention that your administration is in receipt of a request to waive the current vaccine mandate for international travelers entering the United States from top-ranked men’s tennis player Novak Djokovic,” the Senators wrote in a letter.

“We write to urge you to grant the requested waiver, which is necessary to allow Mr. Djokovic to compete in the Miami Open professional tennis tournament held in our home state of Florida beginning March 19, 2023,” the pair added.

The letter continues, “In September 2022, you plainly declared to a national audience on 60 Minutes that ‘the [COVID-19] pandemic is over,’ and, earlier this year, Dr. Anthony Fauci published a professional article acknowledging the limited efficacy of vaccines in protecting against respiratory pathogens, like the novel coronavirus.”

“In light of these changing circumstances, and admissions by you and members of your own administration, the current restrictive vaccine mandate which you have maintained for international travelers entering the United States seems outdated and worthy of rescission,” the Senators urge.

They add, “Mr. Djokovic is a world-class athlete in peak physical condition who is not at high-risk of severe complications from COVID-19. It seems both illogical and misaligned with the opinions of your own administration to not grant him the waiver he requests so that he may travel to the U.S. to compete in a professional event.”

How long are they going to carry on with this?


Follow on Twitter:

Brand new merch now available! Get it at PJW Shop

ALERT! In the age of mass Silicon Valley censorship It is crucial that we stay in touch.

We need you to sign up for our free newsletter here.

Support our sponsor – Turbo Force – a supercharged boost of clean energy without the comedown.

Also, we urgently need your financial support here. ———————————————————————————————————————

  • Continue Reading


    Moderna Backpedals, Guarantees ‘Free’ Covid-19 Vaccines After Demand Collapses



    Zero Hedge

    JOHAN ORDONEZ/AFP via Getty Images

    mRNA vaccine maker Moderna has backpedaled on a January plan to charge $110 to $130 per dose of Covid-19 vaccine (up from $26 per dose for booster shots), and is now promising that people won’t have to pay for the jab once the US Government stops buying shots.

    “Moderna remains committed to ensuring that people in the United States will have access to our COVID-19 vaccines regardless of ability to pay,” the company said in a statement, adding that the vaccine “will continue to be available at no cost for insured people whether they receive them at their doctors’ offices or local pharmacies.”

    Those without insurance – or whose insurance is inadequate, will be able to get jabbed “at no cost” via a Moderna assistance program.

    As The Epoch Times notes,

    Because the COVID-19 vaccines were added to the child immunization schedule, children whose families cannot pay for the vaccine will be eligible to receive them for free, with taxpayers covering the cost.

    That would happen through a program called Vaccines for Children.

    Advisers to the government, who recommended the addition to the schedule, said it was because the vaccines can prevent severe illness. The new vaccines, poised to replace the original shots, are not backed by any clinical trial data yet.

    Dr. Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention (CDC), said that the only reason the vaccines were placed on the schedule was so they could be covered by the Vaccines for Children program.

    “It was the only way that our uninsured children would be able to have access to the vaccines,” Walensky said during a congressional hearing on Feb. 8. “That was the reason to put it on the schedule.”

    *  *  *

    The announcement comes amid a collapse in demand for Covid-19 vaccines.

    According to analyst estimates, Pfizer, Moderna, Gilead Sciences, AstraZeneca and Merck could suffer a drop in sales of nearly two-thirdsReuters reports.

    “We remain skeptical that COVID revenues will grow in 2024 and beyond,” said JPMorgan analyst Chris Schott in a recent research note, adding that vaccination rates could drop even further than the significant decline already seen in booster shots last year.

    Moderna also expects 2023 revenue to drop sharply.

    The company’s only product – its messenger RNA COVID vaccine – pulled in around $18.4 billion in 2022. Analysts expect that to drop to around $7 billion in 2023. The company is due to report earnings later this month.

    Oppenheimer & Co analyst Hartaj Singh said investors are “frustrated Moderna hasn’t used their firepower more effectively to prepare for revenues and earnings going down in 2023 or 2024.” -Reuters

    What changed?

    This post was originally published at Zero Hedge

    Continue Reading


    “The Trials Should Have Been Halted”: Rate Of ‘Serious Adverse Events’ Closely Tracks Spike In Post-Vax Disabilities



    Zero Hedge

    GRANT HINDSLEY/AFP via Getty Images

    Over the past 18 months, skeptics of mRNA Covid-19 vaccines and those pointing out high rates of adverse reactions have been subject to ostracism, deplatforming, and flawed ‘fact checks‘ to shut down opinions and analysis which conflicted with official narratives.

    Now, the data has begun to speak for itself, thanks to people like former Blackrock portfolio manager Ed Dowd, who has devoted the last several years to deep-dive research and analysis of pandemic-related data (in fact, he’s written an excellent book on the topic). Dowd, along with partners Carlos Alegria and Yuri Nunes, launched Phinance Technologies – where, aside from traditional macroeconomic analysis, they have produced comprehensive reports on pandemic-related disabilities and excess deaths using official data.

    Their latest analysis reveals that the rate of Serious Adverse Events in the mRNA Covid-19 vaccine clinical trials closely tracks a spike in disabilities reported after the vaccine rollout.

    Via Phinance Technologies (emphasis ours), 

    In part 3 of our US disabilities analysis we observed that the rise in disability rates post 2/2021 correlates closely with the rollout of the vaccination schedule. When looking at changes in disabilities on a wider time frame (since 2008) we observe that the disability rates rose or fell from month to month but tended to be relatively stable over time. However, as shown in part 1the change in behaviour since early 2021 is clearly an abnormal occurrence with high level of statistical significance. It happens to be highly correlated to the cumulative Covid-19 vaccine rollout, but we cannot state that the correlation is statistically meaningful as it is based on a cumulative plot with obvious autocorrelation.

    In this section we provide further evidence that the most likely cause of the rise in disabilities is the Covid-19 vaccines. For that purpose, we model the expected rise in disabilities due to the vaccination rollout in the general population. We do so by using the rates of Serious Adverse Events (SAEs) obtained by the safety analysis of the mRNA vaccine (Pfizer and Moderna) clinical trials, performed in the Vaccine journal paper we reviewed here, and our analysis in part five.

    We can observe that the rate of rise in disabilities is higher than the computed rate of rise in SAEs of special interest, which could be explained in several different ways, or by a combination of factors.

    • By the definition of an SAEs of special interest being more extreme than the rate of disabilities reported by the individuals surveyed by the BLS i.e. some disabilities reported by the individuals surveyed by the BLS may be caused by adverse events that are not deemed SAEs of special interest, due to the criteria used to define an SAE being overly restrictive.
    • The population of the Civilian Labor Force as a whole may be less healthy (and somehow more vulnerable to vaccine-related disabilities) than the vaccine trial populations, either due to the selection criteria for participation in the trial, or ‘self-selection’ bias.
    • Under-reporting of SAEs of special interest in the trial populations.
    • Other factors causing excess disabilities in the Civilian Labor Force in a concurrent timeframe to the vaccine rollout.

    As Dowd further notes via Twitter;

    The rate of estimated SAEs appears to be under-reported relative the recorded rise in disabilities (according to the BLS survey) by about 2.6 times. These results were expected as we had already shown in part 3 of our study the high correlation between the rise in the disability rate since 2/21 with the vaccine rollout. We realise that performing the correlation of cumulative time series is misleading & the R2 should not be taken as an indication of establishing a statistically significant relationship as both time series have autocorrelation.”

    Bottom line: There were enough safety signals to show that what we are seeing in the BLS data was known during the clinical trials even given their narrow definition of a SAE. The trials should have been halted. 

    This post was originally published at Zero Hedge

    Continue Reading